Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk
Researchers have identified the mechanism by which a common genetic mutation increases liver disease risk. Their findings suggest…
Stereoselective Effects and Its Potential Mechanism of Ofloxacin on the Growth and Development of Rana Nigromaculata: Mainly Liver Lipid Metabolism
Newswise — Researchers from College of Environment, Hohai University, et al. have conducted a study entitled “Stereoselective effects and its potential…
CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management
The identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how clinicians…